Equities

Quoin Pharmaceuticals Ltd

QNRX:NAQ

Quoin Pharmaceuticals Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)0.7651
  • Today's Change0.005 / 0.67%
  • Shares traded39.53k
  • 1 Year change-86.48%
  • Beta1.8884
Data delayed at least 15 minutes, as of May 20 2024 20:17 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Quoin Pharmaceuticals Ltd, former Cellect Biotechnology Ltd, is an Israel-based specialty pharmaceutical company, focused on developing and commercializing therapeutic products that treat rare and orphan diseases. The Company’s first lead product is QRX003, a once daily, topical lotion comprised of a broad-spectrum serine protease inhibitor, formulated with the proprietary Invisicare technology, to treat Netherton Syndrome. The product going to be developed for other rare dermatological diseases including Peeling Skin Syndrome, SAM Syndrome, and Palmoplantar Keratoderma. Quoin is also developing QRX004 as a potential treatment for Dystrophic Epidermolysis Bullosa, and QRX006 as a potential therapy for an, as of yet, undisclosed rare skin disease.

  • Revenue in USD (TTM)0.00
  • Net income in USD-8.41m
  • Incorporated1986
  • Employees4.00
  • Location
    Quoin Pharmaceuticals Ltd23 Hata'as StreetKFAR SABA 44425IsraelISR
  • Phone+972 99741444
  • Fax+972 97678750
  • Websitehttps://quoinpharma.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Novelstem International Corp12.00k-4.19m2.81m15.00------234.41-0.0893-0.08930.0003-0.04160.0053--2.00---171.11---188.15-------32,373.50-----9.822.20--0.00---446.84------
Eloxx Pharmaceuticals Inc0.00-20.48m2.83m18.00---------9.06-9.060.00-6.530.00----0.00-124.43-115.27---155.33-----------16.69--------45.95---22.56--
Resonate Blends Inc16.47k-1.42m2.84m6.00------172.21-0.0178-0.01780.0002-0.02470.0237-------203.52-680.29-----593.02-78.88-8,597.33-12,895.26---0.46917.89---66.73-56.57-316.63------
Avenue Therapeutics Inc0.00-7.18m2.87m3.00--0.7762-----39.36-39.360.004.810.00----0.00-123.08-186.91-1,045.52-287.70------------0.00-------192.15------
Mosaic Immunoengineering Inc0.00-1.01m2.90m3.00---------0.1397-0.13970.00-0.81070.00----0.00-457.45-----------------35.84--------57.65------
Regen BioPharma Inc236.58k-851.69k2.90m1.00------12.26-0.2271-0.22710.0633-1.260.8644--3.98236,580.00-327.54-104.36---------378.93-275.00---1.32----0.441618.79-58.11------
Axim Biotechnologies Inc39.77k-8.06m2.91m6.00------73.29-0.0366-0.03660.0001-0.03110.0095----6,628.33-193.43-154.34---390.73-----20,265.75-36,362.71---0.62----345.05-27.38-29.10------
Veritas Farms Inc730.65k-6.15m2.95m17.00--14.57--4.04-0.1319-0.13190.01360.00130.08770.80647.8042,979.41-69.02-72.11-123.21-93.59-220.0924.07-787.27-177.790.1392-5.560.95---63.42-0.942723.68---52.93--
Livewire Ergogenics Inc67.98k-1.09m2.98m1.00------43.78-0.0061-0.00610.0003-0.00220.19791.742.8667,980.00-317.45-------113.70---1,604.38--0.1248-2.13----68.58---3.64------
Biostax Corp0.00-1.65m3.01m-----------0.0198-0.01980.00-0.04560.00-------193.36-75.14---------------8.97--------53.32------
Quoin Pharmaceuticals Ltd - ADR0.00-8.41m3.02m4.00--0.3161-----8.38-8.380.002.400.00----0.00-48.65-110.18-64.24-152.79------------0.2699------8.05------
Target Group Inc5.64m228.87k3.05m46.0038.08--2.870.54150.00010.00010.0088-0.01150.7648.60124.27115,104.103.10-37.99---78.7643.71--4.06-586.970.07360.01493.10----577.8392.84---58.54--
Finch Therapeutics Group Inc0.00-16.28m3.12m18.00--0.1636-----10.14-10.140.0011.860.00-------25.22---28.97--------------0.00---87.57--34.80------
AccuStem Sciences Inc0.00-2.05m3.14m3.00---------0.1807-0.18070.00-0.18610.00----0.00-382.02--------------------------45.26------
Optimus Healthcare Services Inc1.27m-7.79m3.20m17.00------2.53-0.1948-0.19480.0317-0.12910.2595--2.1674,453.53-159.79---2,228.37--77.90---615.77--0.1525-15.4121.18--------------
Data as of May 20 2024. Currency figures normalised to Quoin Pharmaceuticals Ltd's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.